Articles From: AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences to ACI Worldwide Brings Complete Mobile Solution to Billers


2013/2/27
REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences investment picks
2013/3/4
- Patients experienced significantly greater reduction in pain as measured by SPID-48 vs.
Sign-up for AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients investment picks
2013/4/17
http://media.marketwire.com/attachments/201304/TN-146516_AcerStarTrekBillboard.pdf.jpg Acer and Paramount Pictures Unite to Promote Acer Mobile Products and New 'Star Trek Into Darkness' Movie http://media.marketwire.com/attachments/201206/47720_acer.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1008278&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Acer and Paramount Pictures Unite to Promote Acer Mobile Products and New "Star Trek Into Darkness" Movie investment picks
2013/5/7
TAIPEI --
Sign-up for Acer to Launch Smaller 8-inch Windows Tablet in June investment picks
2013/4/24
PORT WASHINGTON, N.Y., April 24, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET) , a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today that Ronald Gold and David Rosen, former owners of the Rising Pharmaceuticals business acquired by ACETO in December 2010, informed the Company that they intend to pursue other opportunities apart from ACETO upon the expiration of their three-year employment agreements on December 31, 2013.
Sign-up for ACETO Announces Management Transition at Its Rising Pharmaceuticals Subsidiary investment picks
2013/2/7
PORT WASHINGTON, N.Y., Feb.
Sign-up for ACETO Board of Directors Declares Quarterly Cash Dividend investment picks
2013/5/9
PORT WASHINGTON, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET) , a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.055 per common share.
Sign-up for ACETO Board of Directors Declares Quarterly Cash Dividend investment picks
2013/4/26
PORT WASHINGTON, N.Y., April 26, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET) , a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it will issue its financial results of operations for its fiscal 2013 third quarter ended March 31, 2013 after the stock market closes on Thursday, May 9, 2013.
Sign-up for ACETO Corporation Schedules Fiscal 2013 Third Quarter Financial Results News Release and Conference Call investment picks
2013/2/7
FISCAL 2013 SECOND QUARTER HIGHLIGHTS (Comparisons to FY 2012 Q2): PORT WASHINGTON, N.Y., Feb.
Sign-up for ACETO Reports Fiscal 2013 Second Quarter Results investment picks
2013/5/9
FISCAL 2013 THIRD QUARTER HIGHLIGHTS (Comparisons to FY 2012 Q3): PORT WASHINGTON, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET) , a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today results of operations for its fiscal 2013 third quarter and nine months ended March 31, 2013.
Sign-up for ACETO Reports Record Fiscal 2013 Third Quarter Net Sales and Gross Profit investment picks
2013/4/18
Optimize motor performance across speeds and simplify commissioning, tuning and motion sequencing using C2000™ Piccolo™ microcontrollers.
Sign-up for Achieve improved motion and efficiency for advanced motor control designs in minutes with TI's new InstaSPIN™-MOTION technology investment picks
2013/4/23
- ACH-3102 deemed safe and well-tolerated following 12 weeks of therapy - - High barrier to resistance demonstrated with no on-treatment virologic breakthrough observed - - Novel NS5A inhibitor study supports differentiated profile of ACH-3102 - NEW HAVEN, Conn., April 23, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced updated interim safety and efficacy results, including early sustained virologic response (SVR4) data, from the pilot Phase 2 trial evaluating once-daily ACH-3102 plus ribavirin (RBV) in treatment-naïve patients with genotype 1b, IL28B CC subtype, chronic hepatitis C virus (HCV) infection.
Sign-up for Achillion Announces Updated Phase 2 Results Including Early Sustained Virologic Response on ACH-3102 Plus Ribavirin in Genotype 1b Treatment-Naive Hepatitis C Patients investment picks
2013/5/15
NEW HAVEN, Conn., May 15, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced the appointment of David Apelian, M.D., Ph.D., MBA, to the position of Executive Vice President and Chief Medical Officer, effective May 28, 2013.
Sign-up for Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team investment picks
2013/4/16
NEW HAVEN, Conn., April 16, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that it has initiated an international Phase 2 clinical trial with sovaprevir and ACH-3102 for the treatment of genotype 1 chronic hepatitis C (HCV). The trial will evaluate an all-oral 12-week interferon-free regimen consisting of sovaprevir, ACH-3102, and ribavirin in patients with chronic HCV who have not received prior therapy.
Sign-up for Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV investment picks
2013/2/27
NEW HAVEN, Conn., Feb.
Sign-up for Achillion Pharmaceuticals Announces Closing of Public Offering investment picks
2013/2/21
NEW HAVEN, Conn., Feb.
Sign-up for Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock investment picks
2013/2/20
NEW HAVEN, Conn., Feb.
Sign-up for Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock investment picks
2013/4/23
- Phase 1 Results Further Demonstrate Potency of ACH-3102 in Genotypes 1a and 1b and Against Resistant HCV- AMSTERDAM, The Netherlands, April 23, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced the presentation of new data demonstrating the efficacy, safety, tolerability, and combinability of ACH-3102, a second-generation, pan-genotypic NS5A inhibitor, at the 48 th Annual Meeting of the European Association for the Study of the Liver (EASL) during the International Liver Congress 2013.
Sign-up for Achillion Presents New Data on ACH-3102 to Treat Hepatitis C at the International Liver Congress investment picks
2013/2/20
- Conference call and webcast to be held today, February 20 th , at 5:00 pm EST - NEW HAVEN, Conn., Feb.
Sign-up for Achillion Reports 2012 Fourth Quarter and Year-End Financial Results investment picks
2013/5/7
NEW HAVEN, Conn., May 7, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three months ended March 31, 2013.
Sign-up for Achillion Reports First Quarter 2013 Financial Results investment picks
2013/2/8
NEW HAVEN, Conn., Feb.
Sign-up for Achillion to Present at the 2013 Leerink Swann Global Healthcare Conference investment picks
2013/5/9
NEW HAVEN, Conn., May 9, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that members of the senior management team will be presenting a company overview at three upcoming investor conferences: The live audio broadcasts and the subsequent archived webcasts of the Company's presentations will be available on the Company's website, http://www.achillion.com , under the "News Center" section.
Sign-up for Achillion to Present at Three Upcoming Investor Conferences investment picks
2013/3/1
NEW HAVEN, Conn., March 1, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that members of the senior management team will be presenting a company overview at two upcoming investor conferences: The live audio broadcasts and the subsequent archived webcasts of the Company's presentations will be available on the Company's website, http://www.achillion.com , under the "News Center" section.
Sign-up for Achillion to Present at Two Upcoming Investor Conferences investment picks
2013/2/19
NEW HAVEN, Conn., Feb.
Sign-up for Achillion to Report Fourth Quarter and Year End 2012 Financial Results and Host Conference Call on February 20, 2013 investment picks
2013/2/20
http://media.marketwire.com/attachments/201302/TN-129376_HD1000_board.jpg Speedster HD10000 http://media.marketwire.com/attachments/201302/57392_Achronixlogoresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=987803&ProfileId=051205&sourceType=1 SANTA CLARA, CA --
Sign-up for Achronix Now Shipping 22nm Speedster22i FPGAs to Customers investment picks
2013/5/13
Synopsys Uniquely Proven for the Emerging New Wave of FinFET-based Process Technology MOUNTAIN VIEW, Calif.
Sign-up for Achronix Tapes Out Industry's First FinFET-based System-on-Chip Using Synopsys' IC Compiler and IC Validator investment picks
2013/4/18
ACI Worldwide (NASDAQ: ACIW) , a leading international provider of payment systems, announced today the benchmark results for processing bulk payments on ACI Money Transfer System ™. The solution offers financial institutions the opportunity to rationalize multiple payment processing systems, each typically with their own hardware, software and support costs, onto a single consolidated solution.
Sign-up for ACI Money Transfer System Demonstrates Consolidated Solution Readiness investment picks
2013/2/19
ACI Worldwide, Inc. (Nasdaq: ACIW) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976 (HSR) in connection with ACI's tender offer for common stock of Online Resources Corporation (NASDAQ: ORCC) was terminated early on February 15, 2013 by the U.S. Federal Trade Commission.
Sign-up for ACI Worldwide Announces Early Termination of HSR Waiting Period for ACI’s Acquisition of Online Resources investment picks
2013/2/13
ACI Worldwide (NASDAQ: ACIW) , a leading international provider of payment systems, announced today the release of the newest version of ACI Proactive Risk Manager ™, the industry’s leading payments fraud detection and mitigation solution for financial institutions, processors and merchant retailers.
Sign-up for ACI Worldwide Arms Financial Institutions to Fight Accelerating Fraud investment picks
2013/4/23
ACI Worldwide (NASDAQ: ACIW) , a leading international provider of payment systems, announced today the availability of ACI Mobile Bill Pay Suite™, which enables billers to deliver a full mobile payment experience to their customers.
Sign-up for ACI Worldwide Brings Complete Mobile Solution to Billers investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences to ACI Worldwide Brings Complete Mobile Solution to Billers
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity